Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Viracept
Active Ingredient: Nelfinavir mesilate 58.5mg/g equivalent 50mg/g nelfinavir free base
Dosage Form: Powder for oral suspension
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: F Hoffmann-La Roche AG, Basel, Switzerland
Note: This product has consent that expires on 12 February 2004.
Product: Viracept
Active Ingredient: Nelfinavir mesilate 292.25mg equivalent 250mg nelfinavir free base
Dosage Form: Film coated tablet
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche AG, Basel, Switzerland
Roche Farma S.A., Leganes (Madrid), Spain
Note: This product has consent that expires on 12 February 2004.
Dated this 18th day of July 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).